Use of 1-MNA to Improve Exercise Tolerance and Fatigue in Patients After COVID-19

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

January 8, 2021

Primary Completion Date

March 5, 2021

Study Completion Date

March 5, 2021

Conditions

Covid19Fatigue Syndrome, Chronic

Interventions

DIETARY_SUPPLEMENT

1-MNA

1-MNA supplementation

Trial Locations (1)

Medical Center, Saint Family Hospital, Lodz

All Listed Sponsors

lead

Michal Chudzik

OTHER

NCT04961476 - Use of 1-MNA to Improve Exercise Tolerance and Fatigue in Patients After COVID-19 | Biotech Hunter | Biotech Hunter